Paper41789657
Cellular and inflammatory characteristics of patient‑derived glioblastoma organoids during in vitro cultivation.
Nojszewski J and 6 others. Oncol Rep, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Cellular and inflammatory characteristics of patient‑derived glioblastoma organoids during in vitro cultivation. Papers, record 41789657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41789657
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cellular and inflammatory characteristics of patient‑derived glioblastoma organoids during in vitro cultivation.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioblastoma | Major topic |
| Organoids | Major topic |
| Brain Neoplasms | Major topic |
| Humans | |
| Tumor Microenvironment | |
| Neoplastic Stem Cells | |
| Female | |
| Male | |
| Cell Proliferation | |
| Cytokines | |
| Middle Aged | |
| Cell Culture Techniques | |
| Aged | |
| Biomarkers, Tumor |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39231832 | Interleukin 6 and cancer resistance in glioblastoma multiforme. | Neurosurg Rev | 2024 | https://conductscience.org/library/papers/39231832 | PubMed |
| 2 | 30992437 | Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. | Nat Commun | 2019 | https://conductscience.org/library/papers/30992437 | PubMed |
| 3 | 32478924 | Management of glioblastoma: State of the art and future directions. | CA Cancer J Clin | 2020 | https://conductscience.org/library/papers/32478924 | PubMed |
| 4 | 40980444 | Effect of focused ultrasound-induced mechanical ablation on stemness and dormancy properties of residual/peri-focally localized glioblastoma cells. | Neurooncol Adv | 2025 | https://conductscience.org/library/papers/40980444 | PubMed |
| 5 | 23719262 | S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23719262 | PubMed |
| 6 | 32905502 | Organoid models of glioblastoma: advances, applications and challenges. | Am J Cancer Res | 2020 | https://conductscience.org/library/papers/32905502 | PubMed |
| 7 | 28340100 | Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging. | Neuro Oncol | 2017 | https://conductscience.org/library/papers/28340100 | PubMed |
| 8 | 23412337 | Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23412337 | PubMed |
| 9 | 34067714 | Patient-Derived Cancer Organoids for Precision Oncology Treatment. | J Pers Med | 2021 | https://conductscience.org/library/papers/34067714 | PubMed |
| 10 | 36809318 | Glioblastoma and Other Primary Brain Malignancies in Adults: A Review. | JAMA | 2023 | https://conductscience.org/library/papers/36809318 | PubMed |
| 11 | 28287634 | Immune microenvironment of gliomas. | Lab Invest | 2017 | https://conductscience.org/library/papers/28287634 | PubMed |
| 12 | 33762574 | HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33762574 | PubMed |
| 13 | 37890573 | Chemokine receptor CXCR4 interacts with nuclear receptor Nur77 and promote glioma invasion and progression. | Brain Res | 2024 | https://conductscience.org/library/papers/37890573 | PubMed |
| 14 | 32825103 | Practical Review on Preclinical Human 3D Glioblastoma Models: Advances and Challenges for Clinical Translation. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32825103 | PubMed |
| 15 | 39781345 | Elevated Serum IL-6 as a Negative Prognostic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Validation. | J Cancer | 2025 | https://conductscience.org/library/papers/39781345 | PubMed |
| 16 | 33364198 | Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy. | Front Oncol | 2020 | https://conductscience.org/library/papers/33364198 | PubMed |
| 17 | 24045166 | Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. | J Neuroimmunol | 2013 | https://conductscience.org/library/papers/24045166 | PubMed |
| 18 | 26896279 | A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. | Cancer Res | 2016 | https://conductscience.org/library/papers/26896279 | PubMed |
| 19 | 34635112 | Opportunities and challenges of glioma organoids. | Cell Commun Signal | 2021 | https://conductscience.org/library/papers/34635112 | PubMed |
| 20 | 40725140 | The Seminal Role of the Proinflammatory Cytokine IL-1β and Its Signaling Cascade in Glioblastoma Pathogenesis and the Therapeutic Effect of Interleukin-1β Receptor Antagonist (IL-1RA) and Tolcapone. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725140 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41789657
GET https://conductscience.org/api/papers/v1/41789657/references?page=2